US40637HAG48 · Corp · USD

Halozyme Therapeutics Inc 144a 0.00% 2031/02

Halozyme Therapeutics Inc 144aUnited StatesPRIV PLACEMENTSenior Unsecured
MID PRICE
97.45
par = 100
YIELD TO MAT.
0.54%
semi-annual
COUPON
0.000%
semi-annual · fixed
MATURITY
2031-02-15
bullet · 4.79y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
4.78 y
1bp ↑ ≈ -0.048% P&L
Convexity
25.19
higher = more curvature
Years to maturity
4.79 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Convertible Bond
iShares
US Convertibles$12.7M▲ $66K0.21%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

20/ 100Early footprint
Interpretation. Minimal institutional footprint, with net accumulation
HOLDERS
1
unchanged in 7d
AGGREGATE EXPOSURE
$12.7M
USD across all
TOP CONCENTRATION
100.0%
largest holder
FLOW
▲ $208K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
97,450 USD
PRICE
97.45

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
HALO 0 02/15/31
FIGI
BBG01YCKQJ97
CUSIP
40637HAG4
ISIN
US40637HAG48
Type
Corp
Issued
2025-11-12
Face value
100 USD
Ticker
HALO 0 02/15/31
Sec. type
PRIV PLACEMENT
Seniority
Senior Unsecured

Issuer curve

HALO · 2 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.